
Theralase Technologies Inc
XTSX:TLT

Intrinsic Value
The intrinsic value of one
TLT
stock under the Base Case scenario is
0.01
CAD.
Compared to the current market price of 0.19 CAD,
Theralase Technologies Inc
is
Overvalued by 94%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Theralase Technologies Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Theralase Technologies Inc
Balance Sheet Decomposition
Theralase Technologies Inc
Current Assets | 1.6m |
Cash & Short-Term Investments | 268.8k |
Receivables | 711.5k |
Other Current Assets | 603.4k |
Non-Current Assets | 1.7m |
PP&E | 605.8k |
Other Non-Current Assets | 1.1m |
Free Cash Flow Analysis
Theralase Technologies Inc
CAD | |
Free Cash Flow | CAD |
Earnings Waterfall
Theralase Technologies Inc
Revenue
|
1m
CAD
|
Cost of Revenue
|
-479.4k
CAD
|
Gross Profit
|
554k
CAD
|
Operating Expenses
|
-4.8m
CAD
|
Operating Income
|
-4.3m
CAD
|
Other Expenses
|
32.3k
CAD
|
Net Income
|
-4.3m
CAD
|
TLT Profitability Score
Profitability Due Diligence
Theralase Technologies Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Theralase Technologies Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
TLT Solvency Score
Solvency Due Diligence
Theralase Technologies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
Theralase Technologies Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TLT Price Targets Summary
Theralase Technologies Inc
According to Wall Street analysts, the average 1-year price target for
TLT
is 0.71 CAD
with a low forecast of 0.71 CAD and a high forecast of 0.74 CAD.
Dividends
Current shareholder yield for TLT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TLT
stock under the Base Case scenario is
0.01
CAD.
Compared to the current market price of 0.19 CAD,
Theralase Technologies Inc
is
Overvalued by 94%.